Analysis of FDA FY2019 Drug GMP Warning Letters

By Barbara W. Unger


In this report, you’ll see a detailed 11-page summary of the drug GMP warning letters issued in FY2019, as well as a comparison of trends since FY2013.

Download the report

Get Complete Access to the Redica Systems Platform

Please submit your email address and one of our team members will contact you shortly to answer all of your questions and get you started with the new Enforcement Analytics platform.

Discover the power of the most comprehensive database of 483s in existence.

Our database of over 20,000 483s is retyped and tagged, making it easy to create an Observation Report in seconds.

Eliminate days of work and get your FREE personalized 483 Observation Report.